GLP-1 drug threat “negligible” to PepsiCo, CEO says
Continued price increases drove positive results as the company’s organic volume fell 2.5% for the latest quarter.
Continued price increases drove positive results as the company’s organic volume fell 2.5% for the latest quarter.